Pricing Log in Create free account

Precision BioSciences, Inc. (DTIL) vs SAB Biotherapeutics, Inc. (SABS)

Precision BioSciences, Inc. and SAB Biotherapeutics, Inc. are both Biotechnology companies. Precision BioSciences, Inc. and SAB Biotherapeutics, Inc. are of similar size ($275.7M and $267.5M). Precision BioSciences, Inc. grew revenue faster over the last twelve months: −11.9% against −60.3%. Across the 14 metrics below, Precision BioSciences, Inc. leads on 8 and SAB Biotherapeutics, Inc. on 6.

Valuation

Metric DTIL SABS Biotechnology median
P/E n/m n/m 10.60
P/S 6.54 147.02 9.40
P/B 5.70 1.11 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 5.22 85.82 9.02
Earnings yield (11.41%) (6.31%) (32.88%)
Free cash flow yield (17.77%) (24.01%) (23.13%)

Profitability

Metric DTIL SABS Biotechnology median
Gross margin 100.00% 100.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (112.69%) (34.27%) (51.96%)
Return on assets (36.04%) (28.97%) (46.06%)
Return on invested capital 0.00% (38.97%) 0.00%

Growth

Metric DTIL SABS Biotechnology median
Revenue growth (TTM) (11.87%) (60.26%) 6.76%
EPS growth (last fiscal year) (442.31%) 78.53% 29.88%
Revenue growth, 5-year CAGR 7.13% — 9.75%
Net income growth, 5-year CAGR 0.00% (26.69%) 0.00%

Health

Metric DTIL SABS Biotechnology median
Debt to equity 0.43 0.01 0.00
Current ratio 10.47 9.22 4.97
Net debt to EBITDA 1.86 2.03 1.01

Dividend

Metric DTIL SABS Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric DTIL SABS Biotechnology median
Market cap 275.73m 267.50m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack